Clinical Analysis of Femur Shaft Insufficiency Fractures

被引:6
作者
Ko, Sang-Bong [1 ]
Lee, Sang-Wook [1 ]
Park, Chang-Min [1 ]
Lee, Sang-Hwa [1 ]
机构
[1] Catholic Univ Daegu, Sch Med, Dept Orthoped Surg, 33 Duryugongwon Ro 17 Gil, Daegu 705718, South Korea
关键词
Femur shaft; Insufficiency fracture; Epidemiologic status;
D O I
10.4055/cios.2012.4.3.227
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: To characterize the recently issued femur shaft insufficiency fracture in terms of a patient's own epidemiological status. Methods: Fourteen patients were treated for insufficiency fracture from July 2002 to June 2008, excluding cases including the risk factors of insufficiency fracture. All patients were female, and their mean age was 75.6 years (range, 65 to 89 years). The mean follow-up period was 50.6 months (range, 14 to 86 months). Results: The mean body weight of the Koreans in the same age group was 58.1 +/- 9.7 kg, and the mean height was 155.5 +/- 8.8 cm. The mean body weight of our insufficiency fracture patients was 45.7 kg and it was statistically significantly lower than that of the Koreans in the same age group (p < 0.001). The mean height was 147.3 cm and it was significantly shorter than the mean height of the Koreans in the same age group (p = 0.002). In regard to menopausal time, the mean menopausal time of the Koreans was 48.0 +/- 4.2 years, it was 44 years in our study, as menopause occurred statistically significantly earlier (p = 0.017). The patients with insufficiency fracture showed statistically lower weight, shorter stature and an earlier menopausal period than that of the general population. Conclusions: In early menopausal, underweight, and short patients prescribed osteoporosis medication for an extended period of time, if predromal symptom is present, it is necessary to suspect insufficiency fracture of the femur.
引用
收藏
页码:227 / 233
页数:7
相关论文
共 13 条
[1]   Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial [J].
Black, DM ;
Thompson, DE ;
Bauer, DC ;
Ensrud, K ;
Musliner, T ;
Hochberg, MC ;
Nevitt, MC ;
Suryawanshi, S ;
Cummings, SR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11) :4118-4124
[2]   Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].
Black, DM ;
Cummings, SR ;
Karpf, DB ;
Cauley, JA ;
Thompson, DE ;
Nevitt, MC ;
Bauer, DC ;
Genant, HK ;
Haskell, WL ;
Marcus, R ;
Ott, SM ;
Torner, JC ;
Quandt, SA ;
Reiss, TF ;
Ensrud, KE .
LANCET, 1996, 348 (9041) :1535-1541
[3]   Ten years' experience with alendronate for osteoporosis in postmenopausal women [J].
Bone, HG ;
Hosking, D ;
Devogelaer, J ;
Tucci, JR ;
Emkey, RD ;
Tonino, RP ;
Rodriguez-Portales, JA ;
Downs, RW ;
Gupta, J ;
Santora, AC ;
Liberman, UA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12) :1189-1199
[4]   Bisphosphonates: Mechanisms of action [J].
Fleisch, H .
ENDOCRINE REVIEWS, 1998, 19 (01) :80-100
[5]  
Fleisch H., 2002, PRINCIPLES BONE BIOL, P1361
[6]   Subtrochanteric insufficiency fractures in patients on alendronate therapy - A caution [J].
Goh, S.-K. ;
Yang, K. Y. ;
Koh, J. S. B. ;
Wong, M. K. ;
Chua, S. Y. ;
Chua, D. T. C. ;
Howe, T. S. .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2007, 89B (03) :349-353
[7]   Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate [J].
Lenart, Brett A. ;
Lorich, Dean G. ;
Lane, Joseph M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (12) :1304-1306
[8]   Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib [J].
Mashiba, T ;
Hirano, T ;
Turner, CH ;
Forwood, MR ;
Johnston, CC ;
Burr, DB .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (04) :613-620
[9]   Low-energy femoral shaft fractures associated with alendronate use [J].
Neviaser, Andrew S. ;
Lane, Joseph M. ;
Lenart, Brett A. ;
Edobor-Osula, Folorunsho ;
Lorich, Dean G. .
JOURNAL OF ORTHOPAEDIC TRAUMA, 2008, 22 (05) :346-350
[10]   Severely suppressed bone turnover: A potential complication of alendronate therapy [J].
Odvina, CV ;
Zerwekh, JE ;
Rao, DS ;
Maalouf, N ;
Gottschalk, FA ;
Pak, CYC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03) :1294-1301